Common chromosomal abnormalities in mycosis fungoides transformation
✍ Scribed by Martina Prochazkova; Edith Chevret; Guillaume Mainhaguiet; Jiri Sobotka; Béatrice Vergier; Marc-Antoine Belaud-Rotureau; Marie Beylot-Barry; Jean-Philippe Merlio
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 242 KB
- Volume
- 46
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
To identify cytogenetic features of large cell transformation in mycosis fungoides (T‐MF), we selected in 11 patients, 16 samples either from skin tumors (13), lymph node (1), or peripheral blood cells (2) collected at the time of the transformation. Comparative genomic hybridization (CGH), G‐banding, fluorescence in situ hybridisation (FISH), multicolour FISH (mFISH), and DNA content analysis were used. Fifteen samples displayed unbalanced CGH profiles, with gains more frequently observed than losses. Recurrent chromosomal alterations were observed for chromosomes 1, 2, 7, 9, 17, and 19. The most common imbalances were gain of chromosome regions 1p36, 7, 9q34, 17q24‐qter, 19, and loss of 2q36‐qter, 9p21, and 17p. In six samples 1p36‐pter gain was associated with 9q34‐qter gain and whole chromosome 19 gain. In five of these samples whole or partial gain of chromosome 17 was also observed. No specific pattern was seen with regard to the expression of the CD30 antigen by tumor cells. Cytogenetics and/or DNA content analysis of skin tumor cells revealed an abnormal chromosome number in all tested cases (n = 7) with DNA ploidy ranging from hyperdiploid (2.78) to hypotetraploid (3.69) (mean 3.14+/−0.38). Thus, T‐MF displayed frequent chromosomal imbalances associated with hypotetraploidy. © 2007 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Cutaneous T‐cell lymphoma (CTCL) is a clonally derived lymphoproliferative disorder that preferentially involves the skin. The two major clinical expressions of CTCL, mycosis fungoides (MF) and Sézary syndrome (SS), have poorly understood pathogenesis. Chromosome abnormalities, mostly c
## Abstract Evolution to myelofibrosis (MF), acute myeloid leukemia or myelodysplastic syndrome (AML/MDS) may occur over time in myeloproliferative neoplasms (MPN) patients most likely due to the acquisition of additional mutations. The Groupe Francophone de cytogenetique hematologique (GFCH) has c
## BACKGROUND. Chromosomal abnormalities in some lymphomas are associated with a poor prognosis. Trisomy 12 and deletions of chromosome 13 have been described in small lymphocytic lymphoma (SLL). To determine whether chromosomal aberrations could be detected by fluorescence in situ hybridization (F